Australia markets closed

Kuros Biosciences AG (CSBTF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
6.30+0.05 (+0.80%)
At close: 10:33AM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
15,155
33,564
17,986
13,815
4,039
Cost of revenue
3,721
9,628
7,217
3,749
2,368
Gross profit
11,434
23,936
10,769
10,066
1,671
Operating expenses
Research development
5,018
5,599
5,194
4,989
4,005
Selling general and administrative
9,650
20,691
11,153
7,381
4,694
Total operating expenses
21,132
37,128
24,215
18,833
13,350
Operating income or loss
-9,698
-13,192
-13,446
-8,767
-11,679
Interest expense
4,598
186
145
1,383
848
Income before tax
-12,935
-13,347
-15,991
-9,554
-12,094
Income tax expense
-1,793
380
-1,396
-2,013
-574
Income from continuing operations
-11,142
-13,727
-14,595
-7,541
-11,520
Net income
-11,142
-13,727
-14,595
-7,541
-11,520
Net income available to common shareholders
-11,142
-13,727
-14,595
-7,541
-11,520
Basic EPS
-0.46
-0.38
-0.43
-0.23
-0.47
Diluted EPS
-0.46
-0.38
-0.43
-0.23
-0.47
Basic average shares
35,121
36,582
33,901
32,794
24,318
Diluted average shares
2,641
36,582
33,901
32,794
24,318